<DOC>
	<DOC>NCT02321852</DOC>
	<brief_summary>The purpose of this study is to investigate the effects of the eNOS activating agent triflusal on episodic memory and cognitive functions in healthy participants.</brief_summary>
	<brief_title>Influence of Triflusal on Cognitive Functions in Healthy Subjects</brief_title>
	<detailed_description>Randomised, placebo controlled, double blind, cross-over design Primary study outcomes are: Performance in picturial and verbal memory tasks. Main secondary outcomes are: Performance in working memory and cognitive tasks and influence on mood, depression and anxiety and motivation. Once daily oral administration of placebo mannitol for 7 days in a cross-over trial with a washout period of at least 14 days between the two periods. Each participant will take triflusal as well as placebo</detailed_description>
	<mesh_term>Mannitol</mesh_term>
	<mesh_term>Triflusal</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<criteria>Healthy Male or female Normotensive BMI between 20 and 27 kg/m2 Aged between 18 and 40 years Native or fluent Germanspeaking Caucasian Female practicing safe contraception Acute or chronic psychiatric or somatic disorder Any contraindication against aspirin or other NSAIDS History of coagulation disease History of gastrointestinal disease Laboratory exclusion criteria: values of blood count, blood chemistry and coagulation status outside normal range Pathological ECG Pregnancy, breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>